This combination also reprograms the immunosuppressive tumor microenvironment by activating the JAK/STAT and IFN-γ pathways, stimulating M1 macrophages and antigen-presenting cells, and promoting CD8+ T-cell infiltration to alleviate extrinsic immunosuppression [186]. The gene discussed is CD8A; the disease is neoplasm.